The risks of medical innovation:risk perception and assessment in historical context

Saved in:
Bibliographic Details
Group Author: Schlich Thomas.; Tr··ohler Ulrich, 1943-
Published: Routledge,
Publisher Address: London
Publication Dates: 2006.
Literature type: Book
Language: English
Series: Routledge studies in the social history of medicine ; 21
Subjects:
Carrier Form: xiii, 291 p.: ill. ; 24 cm.
ISBN: 0415334810 (hardback)
9780415334815 (hardback)
9780415334815
Index Number: R
CLC: R-19
R-09
Call Number: R-09/R595
Contents: Includes bibliographical references and indexes.
Risk and medical innovation : a historical perspective / Thomas Schlich -- To assess and to improve : practitioners' approaches to doubts linked with medical innovations 1720-1920 / Ulrich Tr··ohler -- Anaesthesia and the evaluation of surgical risk in mid-nineteenth century Britain / Ian Burney -- Redemption, danger and risk : the history of anti-bacterial chemotherapy and the transformation of tuberculin / Christoph Gradmann -- "As safe as milk or sugar water" : perceptions of risks and benefits of the BCG vaccine in the 1920s and 1930s in France and Germany / Christian Bonah -- From danger to risk : the perception and regulation of X-rays in Switzerland 1896-1970 / Monika Dommann -- The population as patient : Alice Stewart and the controversy over low-level radiation in the 1950s / Sarah Dry -- To treat or not to treat : drug research and the changing nature of essential hypertension / Carsten Timmermann -- Hormones at risk : cancer and the medical uses of industrially-produced sex steroids in Germany, 1930-1960 / Jean-Paul Gaudilli·Øere -- Risk assessment and medical authority in operative fracture care in the 1960 and 1970s / Thomas Schlich -- Assessing the risk and safety of the pill : maternal mortality and the pill / Lara Marks -- Addressing uncertainties : the conceptualisation of brain death in Switzerland 1960-2000 / Silke Bellanger and Aline Steinbrecher -- Risk on trial : the interaction of innovation and risk in cancer clinical trials / Peter Keating and Alberto Cambrosio -- BioRisk : interleukin-2 from laboratory to market in the United States and Germany / Arthur Daemmrich -- The redemption of Thalidomide : standardizing the risk of birth defects / Stefan Timmermans and Valerie Leiter.